Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Plos One|September 25, 2014
Association between gene expression profiles and clinical outcome of pemetrexed-based treatment in patients with advanced non-squamous non-small cell lung cancer: exploratory results from a phase II studyDean A Fennell, Scott P Myrand, Tuan S Nguyen, et al.Molecular Cancer Therapeutics|May 28, 2021
First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody-Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric CancerMark D Pegram, Erika P Hamilton, Antoinette R Tan, et al.Immunotherapy|September 12, 2024
A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumorsBen Tran, Mark Voskoboynik, Johanna Bendell, et al.Journal of Medical Microbiology|January 15, 2009
Vibrio cholerae O1 clinical strains isolated in 1992 in Kolkata with progenitor traits of the 2004 Mozambique variantSouvik Chatterjee, Tapas Patra, Kausik Ghosh, et al.Journal of Clinical Pharmacology|February 28, 2023
Population Pharmacokinetics of Monalizumab in Patients With Advanced Solid TumorsMichael Hwang, Chunling Fan, Mun Sang Yue, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 1, 2013
Thymidylate synthase expression and outcome of patients receiving pemetrexed for advanced nonsquamous non-small-cell lung cancer in a prospective blinded assessment phase II clinical trialMarianne C Nicolson, Dean A Fennell, David Ferry, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Evaluation of antitumor activity using change in tumor size of the survivin antisense oligonucleotide LY2181308 in combination with docetaxel for second-line treatment of patients with non-small-cell lung cancer: a randomized open-label phase II studyRonald Natale, Fiona Blackhall, Dariusz Kowalski, et al.Journal for Immunotherapy of Cancer|February 3, 2024
Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumorsSandip P Patel, Teresa Alonso-Gordoa, Susana Banerjee, et al.Nature Communications|December 31, 2024
Multifunctional 2D FETs exploiting incipient ferroelectricity in freestanding SrTiO<sub>3</sub> nanomembranes at sub-ambient temperaturesDipanjan Sen, Harikrishnan Ravichandran, Mayukh Das, et al.Science Advances|May 15, 2026
Controlling thermoreversibility and hole conductivity in thermoresponsive ionic biogels using phase morphology for neurohapticsAnkan Dutta, Md Abu Sayeed Biswas, Ethan Gerhard, et al.Pageof 4